Ivan P. Gergel's Net Worth

$13.7 Million

Estimate Recalculated Sep 9, 2024 12:31AM EST

Who is Ivan P. Gergel

Ivan P. Gergel has an estimated net worth of $13.7 Million. This is based on reported shares across multiple companies, which include NEKTAR THERAPEUTICS, FOREST LABORATORIES INC, Corium International, Inc., Neurotrope, Inc., Endo International plc, ENDO HEALTH SOLUTIONS INC., and INDEVUS PHARMACEUTICALS INC.

SEC CIK

Ivan P. Gergel's CIK is 0001328288

Past Insider Trading and Trends

2014 was Ivan P. Gergel's most active year for acquiring shares with 9 total transactions. Ivan P. Gergel's most active month to acquire stocks was the month of November. 2014 was Ivan P. Gergel's most active year for disposing of shares, totalling 24 transactions. Ivan P. Gergel's most active month to dispose stocks was the month of January. 2013 saw Ivan P. Gergel paying a total of $2,181,470.82 for 164,235 shares, this is the most they've acquired in one year. In 2014 Ivan P. Gergel cashed out on 384,194 shares for a total of $7,264,132.69, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NEKTAR THERAPEUTICS

SVP & Chief Medical Officer
Updated Nov 17, 2017
Form 4
156.29%
64.98K
$44.23
-$222.12K
Nov 17, 2017
106.55K
Acquisition
Nov 15 - Nov 16
Form 4
-21.96%
-100.00K
$17.59
-$1.31M
Oct 03, 2017
355.33K
Sale
ScheduledSep 29 - Oct 02
Form 4
-4.58%
-2.00K
$19.32
-$38.58K
Aug 18, 2017
41.58K
Sale
Aug 16
Form 4
-10.72%
-54.92K
$16.07
-$552.50K
Jul 20, 2017
457.32K
Sale
ScheduledJul 18
Form 4
-8.09%
-45.08K
$16.06
-$452.63K
Jul 13, 2017
512.24K
Sale
ScheduledJul 11 - Jul 12
Form 4
-3.22%
-1.45K
$19.55
-$28.35K
May 18, 2017
43.57K
Sale
May 16
Form 4
-3.13%
-1.46K
$13.14
-$19.14K
Feb 17, 2017
45.02K
Sale
Feb 16
Form 4
264.36%
70.00K
Dec 15, 2016
96.48K
Grant
Dec 13
Form 4
-3.10%
-848.00
$13.96
-$11.84K
Nov 18, 2016
26.48K
Sale
Nov 16
Form 4
-5.81%
-1.69K
$17.56
-$29.59K
Aug 17, 2016
27.33K
Sale
Aug 16
Form 4
5,095.33%
77.50K
Jul 18, 2016
79.02K
Grant
Jul 14
Form 4
-2.99%
-432.00
$13.58
-$5.87K
May 18, 2016
14.01K
Sale
May 16 - May 17
Form 4
-3.71%
-556.00
$11.92
-$6.63K
Feb 18, 2016
14.44K
Sale
Feb 16 - Feb 17
Form 4
100.00K
Feb 05, 2016
100.00K
Grant
Feb 03
Form 4/A
27.50K
Jan 15, 2016
27.50K
Grant
Dec 15
Form 4
27.50K
Dec 17, 2015
27.50K
Grant
Dec 15
Form 4
100.00K
Dec 11, 2014
100.00K
Grant
Dec 09
Form 4
550.00K
May 19, 2014
550.00K
Grant
May 19
Form 3
May 19, 2014
Showing 19 results

FOREST LABORATORIES INC

Sr VP - Chief Sci. Officer
Updated Jan 29, 2008
Form 4/A
30.00K
Jan 29, 2008
30.00K
Grant
Dec 06
Form 4
45.00K
Jan 08, 2008
45.00K
Grant
Dec 06
Form 4
45.00K
Dec 10, 2007
45.00K
Grant
Dec 06
Form 4
-34.48%
-32.25K
$46.16
-$468.11K
Feb 16, 2007
61.27K
Sale
Feb 14
Form 4
75.00K
Dec 12, 2006
75.00K
Grant
Dec 08
Form 5
75.00K
May 05, 2006
75.00K
Grant
Aug 08
Form 4
-91.43%
-16.00K
$30.67
-$306.23K
Jun 21, 2005
1.50K
Sale
Jun 17
Form 3
May 27, 2005
Showing 8 results

Corium International, Inc.

Investor
Updated Nov 28, 2018
Form 4
-100.00%
-62.00K
$12.50
-$775.00K
Nov 28, 2018
Disposition
Nov 27
Form 4
15.00K
Dec 05, 2017
15.00K
Grant
Dec 01
Form 4
15.00K
Dec 27, 2016
15.00K
Grant
Dec 22
Form 4
12.00K
Dec 22, 2015
12.00K
Grant
Dec 18
Form 4
20.00K
Dec 08, 2014
20.00K
Grant
Dec 04
Form 3
Dec 08, 2014
Showing 6 results

Neurotrope, Inc.

Investor
Updated Dec 03, 2020
Form 4
-100.00%
-52.81K
Dec 03, 2020
Disposition
Dec 01
Form 4
15.00K
Nov 27, 2020
15.00K
Grant
Nov 24
Form 4
10.00K
Mar 24, 2020
10.00K
Grant
Mar 20
Form 4
10.00K
Apr 15, 2019
10.00K
Grant
Mar 15
Form 4
10.00K
Jan 24, 2019
10.00K
Grant
Jan 22
Form 4
7.81K
Dec 17, 2018
7.81K
Grant
Dec 13
Form 3
Dec 17, 2018
Showing 7 results

Endo International plc

EVP, R&D and CSO
Updated Mar 11, 2014
Form 4
-48.60%
-75.64K
$51.80
-$3.13M
Mar 11, 2014
79.98K
Sale
Mar 10
Showing 1 results

ENDO HEALTH SOLUTIONS INC.

EVP, R&D and CSO
Updated Mar 03, 2014
Form 4
-100.00%
-209.73K
Mar 03, 2014
Disposition
Feb 28
Form 4
-5.83%
-3.36K
$79.06
-$785.48K
Feb 28, 2014
54.21K
Grant
Feb 26 - Feb 27
Form 4
-9.34%
-3.05K
$77.26
-$235.49K
Feb 25, 2014
29.58K
Tax
Feb 22 - Feb 23
Form 4
-45.66%
-10.13K
$75.22
-$761.75K
Feb 21, 2014
12.05K
Tax
Feb 19
Form 4
20.35%
8.69K
Jul 10, 2013
51.40K
Grant
Jul 01
Form 4
-89.78%
-138.22K
$28.60
-$2.86M
Apr 26, 2013
15.74K
Sale
ScheduledApr 24
Form 4
59.62%
15.95K
Mar 15, 2013
42.71K
Grant
Mar 08
Form 4
34.40K
Mar 01, 2013
34.40K
Grant
Feb 27
Form 4
-45.73%
-10.25K
$28.74
-$301.83K
Feb 28, 2013
12.16K
Tax
Feb 26 - Feb 27
Form 4
-16.30%
-3.62K
$25.89
-$380.71K
Jan 03, 2013
18.57K
Options
Dec 31
Form 4
263.25%
70.11K
$34.79
-$35.62K
Feb 24, 2012
96.74K
Grant
Feb 22 - Feb 23
Form 4
-50.00%
-12.50K
$32.21
-$179.62K
May 04, 2011
12.50K
Sale
ScheduledMay 03
Form 4
-25.00%
-30.60K
$27.85
-$484.75K
Mar 03, 2011
91.81K
Sale
ScheduledFeb 28 - Mar 02
Form 4
83.28%
52.44K
$27.10
-$204.33K
Feb 25, 2011
115.41K
Sell-Options
ScheduledFeb 23 - Feb 24
Form 4
-32.25%
-55.60K
$29.38
-$795.76K
Dec 07, 2010
116.81K
Sale
Dec 03
Form 4
107.33K
Feb 23, 2010
107.33K
Grant
Feb 19
Form 4
138.14K
Mar 02, 2009
138.14K
Grant
Feb 26
Form 3
May 02, 2008
Showing 18 results

INDEVUS PHARMACEUTICALS INC

Investor
Updated Mar 03, 2009
Form 3
Mar 03, 2009
Showing 1 results